Do Biologic Therapies for Rheumatoid Arthritis Offset Treatment-Related Resource Utilization and Cost? A Review of the Literature and an Instrumental Variable Analysis-Reference-Cited by-同舟云学术

Do Biologic Therapies for Rheumatoid Arthritis Offset Treatment-Related Resource Utilization and Cost? A Review of the Literature and an Instrumental Variable Analysis

Published:2017-07-27 Issue:9 Volume:19 Page:
ISSN:1523-3774
Container-title:Current Rheumatology Reports
language:en
Short-container-title:Curr Rheumatol Rep

Author:

Bansback Nick,Fu Eric,Sun Huiying,Guh Daphne,Zhang Wei,Lacaille Diane,Milbers Katherine,Anis Aslam H.

Funder

Canadian Initiative for Outcomes in Rheumatology Care

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://link.springer.com/article/10.1007/s11926-017-0680-6/fulltext.html

Reference50 articles.

1. Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. PharmacoEconomics. 2004;22:1.

2. Kavanaugh A. Economic consequences of established rheumatoid arthritis and its treatment. Best Pract Res Clin Rheumatol. 2007;21(5):929–42.

3. Chaudhari K, Rizvi S, Syed BA. Rheumatoid arthritis: current and future trends. Nat Rev Drug Discov. 2016;15:305–6.

4. Kalkan A, Hallert E, Bernfort L, Husberg M, Carlsson P. Costs of rheumatoid arthritis during the period 1990–2010: a register-based cost-of-illness study in Sweden. Rheumatology. 2014;53(1):153–60.

5. Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EMA, et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis. 2010;69(6):976–86.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population‐Based Study;Arthritis Care & Research;2020-12-30

2. Pharmacoeconomics of Biologic Medicines and Biosimilars;Biologics, Biosimilars, and Biobetters;2020-12-30

3. Comorbidities Before and After the Diagnosis of Rheumatoid Arthritis: A Matched Longitudinal Study;ACR Open Rheumatology;2020-10-26

4. Presence of anti-citrullinated protein antibodies and costs and disease activity in early rheumatoid arthritis - a 3-year follow-up;Scandinavian Journal of Rheumatology;2020-07-20

5. Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population–Based Analysis;American Journal of Gastroenterology;2020-01